ArticleActa pharmaceutica Sinica. B2020

Lineage reprogramming of fibroblasts into induced cardiac progenitor cells by CRISPR/Cas9-based transcriptional activators.

Jianglin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.